Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Staudt

Showing results (101-110 of 286) with videos related to

Pageof 29
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2016
Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1Joseph D Dekker, Daechan Park, Arthur L Shaffer, et al.
Cancer Research|December 1, 2018
TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by IbrutinibEman L Dadashian, Erin M McAuley, Delong Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2020
Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14Jaewoo Choi, James D Phelan, George W Wright, et al.
British Journal of Haematology|June 16, 2025
The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomasRahul Lakhotia, Christopher Melani, Stefania Pittaluga, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
Characterization of early stages of human B cell development by gene expression profilingMarit E Hystad, June H Myklebust, Trond H Bø, et al.
Blood Neoplasia|June 23, 2025
A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignanciesMax J Gordon, Sigrid Dubois, Milos D Miljkovic, et al.
Cell|November 30, 2007
Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulationFengyi Wan, D Eric Anderson, Robert A Barnitz, et al.
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer researchJ Carl Barrett, L Michelle Bennett, Laura Kay Fleming, et al.
Leukemia|May 29, 2024
Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibitionRuiqi Zhu, Courtney M Shirley, S Haihua Chu, et al.
Blood|May 13, 2004
Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression responseAndreas Rosenwald, Eric Y Chuang, R Eric Davis, et al.
Pageof 29

Showing results (101-110 of 286) with videos related to

Sort By:
Pageof 29
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2016
Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1Joseph D Dekker, Daechan Park, Arthur L Shaffer, et al.
Cancer Research|December 1, 2018
TLR Signaling Is Activated in Lymph Node-Resident CLL Cells and Is Only Partially Inhibited by IbrutinibEman L Dadashian, Erin M McAuley, Delong Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2020
Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14Jaewoo Choi, James D Phelan, George W Wright, et al.
British Journal of Haematology|June 16, 2025
The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomasRahul Lakhotia, Christopher Melani, Stefania Pittaluga, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
Characterization of early stages of human B cell development by gene expression profilingMarit E Hystad, June H Myklebust, Trond H Bø, et al.
Blood Neoplasia|June 23, 2025
A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignanciesMax J Gordon, Sigrid Dubois, Milos D Miljkovic, et al.
Cell|November 30, 2007
Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulationFengyi Wan, D Eric Anderson, Robert A Barnitz, et al.
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer researchJ Carl Barrett, L Michelle Bennett, Laura Kay Fleming, et al.
Leukemia|May 29, 2024
Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibitionRuiqi Zhu, Courtney M Shirley, S Haihua Chu, et al.
Blood|May 13, 2004
Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression responseAndreas Rosenwald, Eric Y Chuang, R Eric Davis, et al.
Pageof 29